{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"10"}],"units":"Participants"}],"groups":[{"description":"All Phase Ib Participants","id":"OG000","title":"All Phase Ib Participants"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"Up to 28 days","title":"Maximum-tolerated Dose of Gamma-secretase Inhibitor RO4929097, Defined as the Dose Level Where no More Than 1 Out of 6 Patients Experience DLT at the Highest Dose Level Below the MAD, Graded According to NCI-CTCAE Version 4.0 (Phase Ib)","type":"PRIMARY","unitOfMeasure":"mg"}